EyePoint Pharmaceuticals (NASDAQ:EYPT – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.41 by ($1.02), reports. EyePoint Pharmaceuticals had a negative net margin of 283.81% and a negative return on equity of 82.21%. The company had revenue […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Rating) saw a large increase in short interest in May. As of May 15th, there was short interest totalling 4,050,000 shares, an increase of 11.3% from the April 30th total of 3,640,000 shares. Based on an average daily volume of 856,300 shares, the short-interest ratio is presently 4.7 days. […]